🇺🇸 FDA
Patent

US 7658364

Ocular therapeutic agent delivery devices and methods for making and using such devices

granted A61KA61K31/565A61K31/58

Quick answer

US patent 7658364 (Ocular therapeutic agent delivery devices and methods for making and using such devices) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/565, A61K31/58, A61K38/13, A61K9/0051